Research on Crystal Deposition Arthropathies

The summary for the Research on Crystal Deposition Arthropathies grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Research on Crystal Deposition Arthropathies: The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the National Institute on Aging (NIA) invite applications for research on improved diagnosis and treatment of the major crystal deposition arthropathies including gout, calcium pyrophosphate dihydrate (CPPD) crystal deposition disease and hydroxyapatite crystal deposition disease (also known as basic calcium phosphate crystallopathy). The applications may be for individual research projects (R01) or for exploratory/developmental grants (R21). The crystal deposition arthropathies constitute significant public health problems. These problems are anticipated to grow in scope in view of the increased number of elderly in our population, and the increasing numbers of people with osteoarthritis predisposing cartilage to calcification disorders. The Request for Applications (RFA) is based, in part, on the scientific opportunities identified in the NIAMS Roundtable held in 2003: "Opportunities for Translational Research on Articular Crystal Deposition Diseases: Gout, CPPD Crystal Deposition Disease, Hydroxyapatite Deposition Arthropathy."